Phase 3 Multiple Sclerosis Trial, Recruiting
Who may be able to join
AI generated eligibility summary. Written by an AI model from the official source data and checked on a sample basis. It can contain mistakes, so confirm anything important against the original source. How we use AI
Who might be able to join this trial:
- People who are willing and able to sign a consent form before any assessments take place.
- People aged 18 to 65 years old (inclusive) at the time of screening.
- People who have been diagnosed with Secondary Progressive Multiple Sclerosis (SPMS) according to a specific set of medical criteria (the 2017 revised McDonald criteria).
- People who have had no recorded MS relapses (sudden worsening of symptoms) in the 24 months before screening.
- People whose level of disability, as measured by a standard MS scale called the EDSS, falls between 3.0 and 6.0 at the time of screening (confirm with trial site what this means for your situation).
- People who have documented evidence that their disability has been getting worse in the 12 months before screening.
Who may not be able to join:
- People who are unwilling or unable to have MRI scans, for example due to claustrophobia or having certain metal implants, a pacemaker, or a defibrillator in their body.
- People who have a significant history of other brain or nervous system conditions, such as stroke, traumatic brain or spinal injury, or other conditions that could look similar to MS.
- People with ongoing drug or alcohol misuse, or serious mental health conditions that could affect their ability to follow the study procedures.
- People who have previously been diagnosed with a serious brain infection called Progressive Multifocal Leukoencephalopathy (PML), or who have had neurological symptoms that could suggest PML.
- Women who are physically capable of becoming pregnant, unless a highly effective form of contraception (less than 1% failure rate per year) is used throughout the study treatment period and for at least one week after stopping treatment.
- People who have significant problems with bleeding or blood clotting at the time of screening.
- People who are taking certain medications that are listed as excluded in the trial protocol (confirm with trial site which medications apply).
- Additional criteria not listed here may also apply, as noted in the full trial protocol.
Important: Always verify eligibility with the trial site directly before applying.
Based on publicly available eligibility criteria from ClinicalTrials.gov. Verify directly with the trial site before acting. This is not medical advice.
Contact this trial
Phone: 1-888-669-6682
Australian sites
Contact details sourced from ClinicalTrials.gov. Verify directly with the trial site before attending.
GP referral letter
Print a one-page summary to share with your doctor.
Trial details
Where this trial is recruiting
7 site(s) in Australia. Confirm current status and contact details directly with the trial site.
Primary endpoints
Time to 6-month confirmed disability progression (6mCDP) on Expanded Disability Status Scale (EDSS)
Can't join this trial?
Data last synced from ClinicalTrials.gov: 13 July 2026. Trial status can change. Always verify current status directly with the trial site before making any decision.